
Longtime HIV Doctors Are Retiring
The first wave of HIV/AIDS doctors are letting go of their duties—if not always their patients. But the need for specialists is still high, especially in the South.

New Study Seeks to Answer COVID-19 Questions For People Living With HIV
The study, funded by amfAR, seeks to answer questions surrounding COVID outcomes for people with HIV versus their HIV-negative peers.

This Week in HIV Research: Factors of Failure
Aug. 26, 2021: Factors associated with virologic failure on injectable cabotegravir + rilpivirine; HIV stigma and misinformation in U.S. organ procurement; fatty liver and CVD risk among PLWH.

COVID-19 Caused a Dip in STI Testing, but Not Necessarily in Cases
A year of restrictions may have resulted in an unprecedented decline in testing for chlamydia and gonorrhea, finds a recent study.
Our Newest Posts

Long-Acting Injectable PrEP Shows “Spectacular Success” Over Daily Pills
In a recent study, bimonthly injections of cabotegravir lowered the risk of contracting HIV by 66% when compared to daily oral Truvada.

This Week in HIV Research: Comorbidity and Continuity
Sep. 2, 2021: COVID-19 vaccine efficacy in PLWH; adding HIV clinic time to clinical rotations; incorporating HIV and comorbidity care; burdens and outcomes among Medicare recipients.

Advances in Treating HIV: Are Personalized bNAb Cocktails the Way of the Future?
A novel HIV therapy may prove most beneficial to people who start ART during the early weeks of infection.

Tracked, Monitored, and Analyzed: Advocates Call for an Immediate Moratorium on Molecular HIV Surveillance
Naina Khanna and Andrew Spieldenner say it's unsafe to collect and share the data of people living with HIV without their consent.

Hepatitis C Criminalization and Restricted Access to Treatment
Rather than criminalizing hepatitis C, activists say, let’s make testing and treatment more accessible.

Ending the HIV Epidemic: Researchers Call for an Equity-Focused Approach
An analysis of data from six U.S. cities makes the case for equity-focused HIV strategies that target reducing racial and ethnic disparities.





